Furthermore, our observation was consistent to our previous study, in which IL-33 induced an increase of S-phase cells, thus promoting proliferation in both primary mouse leukaemia cells and patient AML samples [9,29]. This evidence concerns the gene IL33 and acute myeloid leukemia.